Showing results (121-130 of 921) with videos related to
Sort By:
Pageof 93
Journal of the Neurological Sciences|August 1, 1991
Nuclear magnetic resonance T2 relaxation times in multiple sclerosisL Rumbach, J P Armspach, D Gounot, et al.Revue Neurologique|January 1, 1990
[Contribution of MRI to the topography of oculomotor disorders in multiple sclerosis]L Rumbach, A M Eber, J L Dietemann, et al.European Journal of Clinical Pharmacology|March 27, 1998
Intraindividual variability of paracetamol absorption kinetics after a semi-solid meal in healthy volunteersG Paintaud, P Thibault, P E Queneau, et al.Revue Neurologique|January 1, 1985
[Contribution to proton nuclear magnetic resonance imaging in multiple sclerosis. Contribution of a multiple spin echo sequence]L Rumbach, M C Caires, J M Warter, et al.Revue Neurologique|June 1, 1994
[Open therapeutic trial of anti-T CD4 monoclonal antibody in multiple sclerosis]L Rumbach, E Racadot, M Bataillard, et al.Neurology|November 1, 1984
Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intakeJ M Warter, C Marescaux, G Chabrier, et al.Revue Neurologique|January 1, 1984
[A genetic form of petit mal absence in Wistar rats]C Marescaux, M Vergnes, G Micheletti, et al.Journal of the Neurological Sciences|February 1, 1983
[Sodium valproate: a hyperammonemic drug. Study in the epileptic and healthy volunteer]C Marescaux, J M Warter, M Laroye, et al.Revue Neurologique|January 1, 1981
[Stuporous states during treatment with sodium valproate. Pathogenetic hypotheses]C Marescaux, L Rumbach, J M Warter, et al.Revue Neurologique|January 1, 1983
[Role of hyperammonemia in stuporous states induced by sodium valproate]J M Warter, C Marescaux, L Rumbach, et al.Pageof 93